This transcript has been edited for clarity.
Robert A. Harrington, MD: Hi. I'm Bob Harrington from Stanford University, here on theheart.org | Medscape Cardiology.
Over the past couple of months of the COVID-19 pandemic, there have been many issues for the clinical cardiovascular community to discuss. One that's at the top of many people's list is how to get information that's reliable out to the clinical and public health communities in a timely way.
I have been thinking about this often, as there have been a few issues with papers being retracted and with preprints not looking anything like the subsequent publications.
I thought it would be worthwhile to bring in two well-known senior investigators, clinicians, and editors from the cardiovascular journal world to have this discussion about how to get this information out in a reliable but timely way, what they think about preprints these days, how they work with their editorial staff and their reviewers to ensure data integrity, and a variety of other topics.
I'm really pleased to be joined by two friends and colleagues. First off, Brahmajee Nallamothu is from the University of Michigan, where he's a professor of internal medicine in the Division of Cardiovascular Medicine.
